Clinical trial
A Study of LY3209590 in Participants With Type 2 Diabetes
NCT03367377
Study timeline
Study start (actual)2018-01-03Date precision: day
Registry last updated2018-12-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Interventions
LY3209590DRUG
Insulin GlargineDRUG · verified · RxNorm: insulin glargine
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03367377 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.